A randomized crossover trial comparing the acute physiological and psychological effects of botanical formulations of oral psilocybin, oral psilocin, and sublingual psilocin
Paper. Tai ML, Szigeti B, Downey AE et al.. Journal of Psychopharmacology, 29 Aug 2026.
Two DMT dosing studies hit participant withdrawals at the high end.
CYB004, a deuterated DMT built for a steadier profile, was only acceptably tolerated at plasma concentrations matching plain DMT; a separate intravenous DMT study had two subjects stop their infusion for anxiety. A 20-person crossover compared whole-mushroom oral psilocybin, oral psilocin and sublingual psilocin.